Structural Heart Devices

Structural Heart Devices

Global Structural Heart Devices Market to Reach US$28.0 Billion by 2030

The global market for Structural Heart Devices estimated at US$13.7 Billion in the year 2023, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Heart Valve Devices, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the Surgical Heart Valves segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 10.0% CAGR

The Structural Heart Devices market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Structural Heart Devices Market - Key Trends and Drivers Summarized

What Role Do Structural Heart Devices Play in Modern Medicine?
Structural heart devices are critical in treating patients with structural heart diseases, including conditions such as aortic stenosis, mitral regurgitation, and atrial septal defects. These devices include heart valves, occluders, annuloplasty rings, and closure devices, which help repair or replace damaged or malformed parts of the heart. The use of minimally invasive technologies, such as transcatheter aortic valve replacement (TAVR), has revolutionized cardiovascular care by reducing the need for open-heart surgery, leading to faster recovery times and reduced hospital stays. As the global population ages and the prevalence of cardiovascular diseases rises, structural heart devices are becoming increasingly essential in addressing the needs of patients who are at higher risk of surgical complications.

What Technological Innovations Are Driving Growth in Structural Heart Devices?
Technological advancements are at the forefront of the structural heart devices market, with innovations focusing on improving device efficacy, reducing procedural risks, and enhancing patient outcomes. One of the most significant developments is in transcatheter technologies, which allow for the repair or replacement of heart valves without open surgery. Improvements in imaging technologies, such as 3D echocardiography and MRI, are also enabling more precise planning and execution of procedures, reducing complications. Additionally, advancements in biocompatible materials are enhancing the durability and performance of heart valves, while the integration of smart technologies is enabling real-time monitoring and post-procedure care.

Which Market Segments Are Leading the Adoption of Structural Heart Devices?
Device types include heart valves, closure devices, occluders, and annuloplasty rings, with heart valves, particularly transcatheter heart valves, dominating the market due to their widespread use in treating valvular heart diseases. Procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are driving demand for minimally invasive devices. End-users include hospitals, ambulatory surgical centers, and specialty clinics, with hospitals being the largest adopters due to their access to advanced medical technologies. North America and Europe are the largest markets for structural heart devices, while Asia-Pacific is rapidly emerging due to improving healthcare infrastructure and increasing awareness of cardiovascular care.

What Is Driving the Growth of the Structural Heart Devices Market?
The growth in the structural heart devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in transcatheter technologies. The aging global population, particularly in developed regions, is driving the demand for heart valve replacements and other structural heart interventions. Technological innovations in imaging and biocompatible materials are enhancing the safety and efficacy of these devices, leading to higher adoption rates. Additionally, increasing healthcare expenditure and government initiatives to improve access to advanced cardiac care are fueling market growth, particularly in emerging markets.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• Braile Biomedica
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Lepu Medical Technology (Beijing) Co., Ltd.
• LivaNova PLC
• Medtronic PLC
• Micro Interventional Devices, Inc.
• TTK Healthcare Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.